Senderra Specialty Pharmacy Patient & Medical Information Form

ADVERTISEMENT

Faxed prescriptions will only be accepted from a prescribing practitioner. Patients must bring an original prescription to the pharmacy, and cannot fax these referral forms to Senderra.
Prescribing Practitioner:
Cardiovascular
Enrollment
NPI:
Address:
Office:
Fax:
Main: 888-777-5547
Fax: 888-777-5645
Contact:
1301 E. Arapaho Rd., Ste. 101
Richardson, TX 75081
E-mail:
PATIENT INFORMATION
Name:
DOB:
SS#:
M
F
_____/_____/__________
_____-_____-__________
Tel:
Al. Tel:
Wt.:
Ht.:
English
Spanish
Other: ________
________
________
Street:
City:
State:
ZIP:
MEDICAL INFORMATION
Statins:
Tried & Failed (Duration):
Not Tolerated:
Contraindication:
Allergies:
Simvastatin
(___________________)
______________________________
Atorvastatin
(___________________)
______________________________
________________
(___________________)
______________________________
Other therapies:
Tried & Failed (Duration):
Not Tolerated:
Contraindication:
Zetia
(___________________)
______________________________
LDL apheresis
(___________________)
______________________________
________________
(___________________)
______________________________
Date of Diagnosis: _____/______/________
Indicate One Primary Diagnosis:
Indicate One Secondary Diagnosis:
E78.0 Pure Hypercholesterolemia (HeFH and HoFH)
I21.__ Acute Myocardial Infarction
I6_.__ Occlusion of Cerebral Arteries (CVA)
E78.2 Mixed Hyperlipidemia
I25.2 Old Myocardial Infarction
G45.__ Transient Cerebral Ischemia (TIA)
I20.8 Other and Unspecified Angina
I67.__ Other and Ill-Defined
E78.5 Other and Unspecified Hyperlipidemia
Pectoris
Cerebrovascular Disease
I25.__ Other Forms of Chronic Ischemic
Other: __________________________________________
Heart Disease
I69.__ History of Stroke With Residuals
I25.10 ASCVD, Unspecified
I70.__ Atherosclerosis
I65.__ Occlusion and Stenosis of
I73.9 Peripheral Vascular Disease,
Precerebral Arteries
Unspecified
***PLEASE FAX COPY OF PRESCRIPTION/MEDICAL CARD, FRONT AND BACK, AS WELL AS ANY CLINICAL NOTES REGARDING THERAPY***
PRESCRIPTION
New
Refill
Ship by: ____/____/____
SHIP TO:
Patient’s Home
Doctor’s Office
Other: ___________________
Refills
Drug
Strength
Directions & Quantity
140mg/mL SureClick autoinjector
Inject 140mg subcutaneously every 2 weeks
(quantity: 2)
Repatha™
Inject 420mg subcutaneously once monthly
(quantity: 3)
140mg/mL pre-filled syringe
*To administer 420mg, give 3 Repatha injections consecutively within 30 minutes*
Pre-Filled Pen
Inject 75mg subcutaneously every 2 weeks (quantity: 2)
Praluent®
Pre-Filled Syringe
Inject 150mg subcutaneously every 2 weeks (quantity: 2)
INJECTION TRAINING
Patient has received pen and injection training
Physician’s office to provide injection training
Senderra Rx to coordinate injection training
PRESCRIBING PRACTITIONER SIGNATURE
To Prescribing Practitioner: By signing this form and utilizing our services, you are also authorizing Senderra Rx to serve as your prior authorization designated agent in dealing with medical
and prescription insurance companies, and co-pay assistance foundations.
Prescribing
Practitioner:
Date:
_______/________/____________
CONFIDENTIALITY NOTICE
IMPORTANT: This fax is intended to be delivered only to the named addressee. It contains material that is confidential, proprietary or exempt from disclosure under applicable law. If you are not the
named addressee, you should not disseminate, distribute, or copy this fax. Please notify the sender immediately if you have received this document in error and then destroy this document immediately.
Cardiovascular Enrollment (Rev. 04/28/2016)

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go